CURRENT REPORT

Company

AYTU BIOPHARMA, INC

Filed

May 2, 2019

Period of Report

May 1, 2019

Accession Number

0001654954-19-005160

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →